⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27258265 | 0.98 | EGFR (0.45) | — | |
| SCHEMBL28276523 | 0.98 | — | — | |
| Trifluoroacetic Acid SCHEMBL28162941 | 0.84 | EGFR (0.35) | — | |
| Quinazoline SCHEMBL27867944 | 0.77 | EGFR (0.77) | — | |
| SCHEMBL28842206 | 0.76 | EGFR (0.37) | — | |
| SCHEMBL11213155 | 0.71 | EGFR (0.38) | — | |
| SCHEMBL8874014 | 0.69 | EGFR (0.58) | — | |
| SCHEMBL29656511 | 0.69 | EGFR (0.43) | — | |
| SCHEMBL29504717 | 0.69 | EGFR (0.43) | — | |
| SCHEMBL137377 | 0.68 | EGFR (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3883932-B1 | INHIBITORS OF GLI1 AS THERAPEUTIC AGENTS | UNIV NEW YORK (US) | 2023-03-29 | — | — | EP | claimed |
| US-20220289753-A1 | SHP2 INHIBITORS | IRBM S.P.A. (IT) | 2022-09-15 | — | — | US | claimed |
| CN-114728935-A | SHP2 inhibitor | IRBM股份公司 | 2022-07-08 | — | — | CN | claimed |
| EP-4010335-A1 | SHP2 INHIBITORS | IRBM S.P.A. (IT) | 2022-06-15 | — | — | EP | claimed |
| WO-2021028362-A1 | SHP2 INHIBITORS | IRBM S.P.A. (IT) | 2021-02-18 | — | — | WO | claimed |
| EP-3772513-A1 | SHP2 INHIBITORS | C.N.C.C.S. S.c.a.r.l. Collezione Nazionale Dei Composti Chimici e Centro Screening (IT) | 2021-02-10 | — | — | EP | claimed |
| CN-105008370-B | tricyclic compounds as CFTR inhibitors | 诺华股份有限公司 | 2017-06-09 | — | — | CN | claimed |
| CN-102238872-A | Organic compounds | INTRA CELLULAR THERAPIES INC | 2011-11-09 | — | — | CN | claimed |
| US-7935824-B2 | Ethylenediamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2011-05-03 | — | — | US | claimed |
| EP-1720878-A1 | HETEROARYL-FUSED PYRAZOLO DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2006-11-15 | — | — | EP | claimed |
| WO-2005085248-A1 | HETEROARYL-FUSED PYRAZOLO DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2005-09-15 | — | — | WO | claimed |
| US-6140033-A | SUPPORT WITH SILVER HALIDE EMULSIONS WITH COUPLERS | EASTMAN KODAK COMPANY (US) | 2000-10-31 | — | — | US | claimed |
| EP-1014185-A1 | Photographic element, pyrazolazole coupler, method for it's preparation and an azomethine dye | EASTMAN KODAK COMPANY (US) | 2000-06-28 | — | — | EP | claimed |
| CN-1258021-A | Photographic material | EASTMAN KODAK CO (US) | 2000-06-28 | — | — | CN | claimed |
| EP-0496617-B1 | Adenosine kinase inhibitors | METABASIS THERAPEUTICS INC (US) | 1999-12-01 | — | — | EP | claimed |
| EP-0055562-B1 | CEPHALOSPORIN DERIVATIVES | ICI PHARMA (FR) | 1986-02-12 | — | — | EP | claimed |
| US-20260138970-A1 | MODULATORS OF THE CALCIUM SIGNALING CASCADE | FONDAZIONE TELETHON ETS (IT) | 2026-05-21 | — | — | US | disclosed |
| WO-2026103730-A1 | DIAZAHETEROCYCLIC DERIVATIVE OF PYRIDOARYL GROUP HAVING KAPPA RECEPTOR ANTAGONISTIC ACTIVITY AND COMPOSITION THEREOF, AND USE | 江苏恩华药业股份有限公司 | 2026-05-21 | — | — | WO | disclosed |
| EP-0055562-B1 | CEPHALOSPORIN DERIVATIVES | ICI PHARMA (FR) | 1986-02-12 | — | — | EP | disclosed |
| US-4010159-A | Pyrrolo[3,4-d]pyrimidines and methods for their preparation | GRUPPO LEPETIT S.P.A. (IT) | 1977-03-01 | — | — | US | disclosed |